Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 25 April at 4:30pm because of system upgrades. We expect to open them again on Friday 26 April at 8am the latest.

Automatic surgical stitching instrument

Reference number
Coordinator Suturion AB
Funding from Vinnova SEK 300 000
Project duration June 2018 - March 2019
Status Completed
Venture Innovative Startups

Purpose and goal

Suturion AB develops and evaluates a suturing device for swift and standardized abdominal closure after surgery. High quality abdominal closure reduces the risk for incisional hernia wich is a large social and economic burden globally. The suturing device minimizes the risk for prick injuries and reduce abdominal closure time wich liberates surgical resources to other patients.

Expected results and effects

Innovativa start-ups phase 1 enabled us to do a regulatory investigation and initiate set-up of the quality management system directed towards CE-registration and FDA-approval. These steps are important for further commercialize the device and to make a multicenter clinical study.

Planned approach and implementation

The project was initiated with a regulatory workshop that identified the pathway towards CE-registration and FDA-approval. The quality management system is organized according outcomes from the workshop by the CTO, CEO and a regulatory expert. We also performed a biocompatibility study and initiated the clinical evaluation study.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 8 January 2019

Reference number 2018-00879

Page statistics